Immunome Inc. — Investor Relations & Filings
Immunome Inc. is a clinical-stage oncology company focused on developing targeted therapies to improve outcomes for cancer patients. The company specializes in creating first-in-class and best-in-class therapeutic candidates, with a primary focus on Antibody-Drug Conjugates (ADCs) and Radioligand Therapies (RLTs). Immunome utilizes a systematic, data-driven process to optimize each component of its drug candidates—antibody, linker, and payload—to address high unmet medical needs. Its clinical pipeline includes varegacestat, a gamma secretase inhibitor in a Phase 3 trial for desmoid tumors; IM-1021, a ROR1-targeted ADC in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand. The company also advances a portfolio of preclinical ADCs targeting various solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Immunome Inc. (0001472012) (Filer) | 2026-04-24 | English | |
| SCHEDULE 13G/A - Immunome Inc. (0001472012) (Subject) | 2026-03-26 | English | |
| 4 - Immunome Inc. (0001472012) (Issuer) | 2026-03-24 | English | |
| 144 - Immunome Inc. (0001472012) (Subject) | 2026-03-20 | English | |
| 10-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English | |
| 8-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 36260617 | ARS - Immunome Inc. (0001472012) (Filer) | 2026-04-24 | English | ||
| 33050365 | SCHEDULE 13G/A - Immunome Inc. (0001472012) (Subject) | 2026-03-26 | English | ||
| 33017259 | 4 - Immunome Inc. (0001472012) (Issuer) | 2026-03-24 | English | ||
| 33000829 | 144 - Immunome Inc. (0001472012) (Subject) | 2026-03-20 | English | ||
| 32892309 | 10-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English | ||
| 32892308 | 8-K - IMMUNOME INC. (0001472012) (Filer) | 2026-03-03 | English | ||
| 29982218 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
|
2025
8 filings
| |||||
| 12302604 | Director's Dealing 2025 | 2025-12-31 | English | ||
| 12302605 | Director's Dealing 2025 | 2025-12-23 | English | ||
| 12302609 | Major Shareholding Notification 2025 | 2025-12-23 | English | ||
| 12302606 | Director's Dealing 2025 | 2025-12-22 | English | ||
| 12302607 | Director's Dealing 2025 | 2025-12-22 | English | ||
| 12302608 | Director's Dealing 2025 | 2025-12-22 | English | ||
| 12302610 | Director's Dealing 2025 | 2025-12-18 | English | ||
| 12302611 | 8-K | 2025-12-17 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Concord Drugs Limited
Develops, manufactures and markets pharmaceutical formulati…
|
538965 | IN | Manufacturing |
|
Công ty Cổ phần Dược Hậu Giang
Leading pharmaceutical enterprise specializing in R&D, manu…
|
DHG | VN | Manufacturing |
|
Công ty Cổ phần Dược phẩm Bến Tre
Pharmaceutical company established in 1963, producing and d…
|
DBT | VN | Manufacturing |
|
Công ty Cổ phần Dược phẩm Cửu Long
Producer of pharmaceuticals, medical equipment, and market-…
|
DCL | VN | Manufacturing |
|
Công ty Cổ phần Dược phẩm Imexpharm
48+ years in pharma manufacturing, EU-GMP certified, offeri…
|
IMP | VN | Manufacturing |
|
Công ty Cổ phần Dược phẩm OPC
Specializes in R&D and production of herbal medicines from …
|
OPC | VN | Manufacturing |
|
Công ty Cổ phần Dược phẩm Trung Ương Vidipha
Reputable manufacturer and distributor of diverse pharmaceu…
|
VDP | VN | Manufacturing |
|
Công ty Cổ phần Dược - Trang thiết bị Y tế Bình Định
Leading pharma and medical equipment company, pioneering in…
|
DBD | VN | Manufacturing |
|
Công ty Cổ phần S.P.M
Leading pharmaceutical manufacturer and distributor of dive…
|
SPM | VN | Manufacturing |
|
Công ty Cổ phần Tập đoàn F.I.T
A diversified economic group in pharmaceuticals, FMCG, real…
|
FIT | VN | Manufacturing |
Immunome Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32238/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32238 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32238 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32238 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32238}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Immunome Inc. (id: 32238)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.